Tenet's $1.9B Conifer Deal Unlocks Cash for AI-Fueled Growth

DALLAS, TX – February 02, 2026 – Tenet Healthcare Corporation (NYSE: THC) today announced a landmark transaction with CommonSpirit Health that reshapes the future of its Conifer Health Solutions subsidiary, injecting significant capital into Tenet and paving the way for aggressive investment in technology. The deal, which sees CommonSpirit exit its joint venture in Conifer, will deliver approximately $1.9 billion in payments to Tenet and coincides with the company previewing robust 2025 financial results, signaling strong operational momentum.

The market responded positively to the news, with Tenet's stock climbing 2% in morning trading as investors and analysts digested the strategic and financial implications of the accretive deal.

Unpacking the Multi-Billion Dollar Arrangement

At the heart of the announcement is a complex but mutually beneficial financial restructuring. CommonSpirit Health will pay Tenet approximately $1.9 billion in installments over the next three years. This process begins with an initial payment of $540 million in the first quarter of 2026, followed by three equal annual installments of $453 million through early 2029.

Simultaneously, Conifer will issue a $540 million redemption payment to CommonSpirit, effectively buying back CommonSpirit's 23.8% equity stake. This move, retroactively effective to January 1, 2026, neatly offsets the initial cash installment from CommonSpirit to Tenet.

The impact on Tenet's balance sheet is substantial. The company projects a reduction of approximately $885 million in redeemable non-controlling interest and other liabilities, coupled with an increase of about $305 million in additional paid-in capital. Tenet executives have framed the transaction as creating a total value of approximately $2.65 billion for the company, a figure that includes the cash payments, the significant reduction of balance sheet liabilities, and the value of reclaiming full ownership of Conifer.

"CommonSpirit worked closely with us to structure a mutually beneficial transaction that reflects our longstanding partnership and commitment to the joint venture," said Saum Sutaria, M.D., Chairman and CEO, of Tenet Healthcare. He noted the deal enables a "thoughtful, collaborative transition over the coming year."

Conifer's New Frontier: AI and Independent Growth

With this transaction, Tenet regains full strategic control of Conifer, a major player in the revenue cycle management (RCM) space that processes around $25 billion in net patient revenue annually for over 600 clients. This independence is not just a change in ownership structure but a catalyst for a new phase of growth and innovation.

Tenet has made it clear that a primary focus will be accelerating Conifer's investments in technology, particularly artificial intelligence and automation. The healthcare RCM industry is rapidly evolving, with providers increasingly turning to technology to enhance efficiency, lower collection costs, and navigate the complex landscape of insurance claims and denials. Conifer plans to be at the forefront of this shift.

The company intends to expand its use of AI algorithms to improve the speed and reliability of processing millions of claims. This includes developing more sophisticated systems for sorting claims and, crucially, for managing and disputing claim denials from insurers—a persistent challenge for healthcare providers. By investing in these global operating capabilities and automated workflows, Conifer aims to solidify its market leadership and deliver greater value to its clients.

"This milestone gives Tenet greater flexibility to support Conifer’s long-term potential," the company stated, emphasizing a commitment to "innovation and market leadership in revenue cycle management services."

CommonSpirit's Strategic Pivot to In-sourcing

For CommonSpirit Health, one of the nation's largest nonprofit health systems, the decision to exit the joint venture and insource its RCM operations marks a significant strategic pivot. The move is a key component of the organization's multiyear system integration and transformation strategy. By bringing these critical functions in-house, CommonSpirit aims to achieve greater operational control and align its revenue cycle more closely with its overarching organizational framework.

The partnership, which dates back to 2012 with the former Catholic Health Initiatives, was praised for its success. Michael Browning, SEVP and CFO of CommonSpirit, described Conifer as a "strong and reliable revenue cycle partner" that brought consistency to a previously fragmented environment. He credited Conifer with meaningfully contributing to its hospitals achieving "100% of their cash collection goals."

Despite the successful collaboration, CommonSpirit's current focus on portfolio realignment and achieving "systemness" across its vast network has driven the strategic decision to manage RCM internally. To ensure a seamless shift, Conifer will continue to provide its services to CommonSpirit through the end of 2026 under the existing contract terms.

"We are grateful for Conifer’s longstanding collaboration and wish them continued success in delivering value to other healthcare systems," Browning stated, underscoring the amicable nature of the transition.

Strong Performance and Market Confidence

The Conifer deal was announced against a backdrop of impressive financial strength for Tenet. The company offered a preliminary glimpse into its full-year 2025 results, estimating that its Adjusted EBITDA will land at the upper end of its guidance range of $4.47 billion to $4.57 billion. This performance was attributed to strong same-store revenue growth and disciplined expense management.

"We continue to deliver strong revenue growth, improved margins and attractive free cash flow as a result of effective execution of our strategies," Sutaria commented.

This combination of a value-creating strategic transaction and robust underlying performance has been well-received by the financial community. Beyond the immediate stock bump, analyst sentiment is overwhelmingly positive. The consensus rating among 16 analysts covering Tenet is a "Buy," with a significant majority recommending either a "Buy" or "Strong Buy."

Following the announcement, TD Cowen adjusted its price target for Tenet to $230 while maintaining a "Buy" rating. Cantor Fitzgerald reiterated its "Overweight" rating and a $245 price target, highlighting the company's growth potential and noting its valuation remains attractive compared to competitors. Further bolstering this confidence, Fitch Ratings recently revised Tenet's outlook from stable to positive, citing strong growth as a key factor. The company plans to provide further details on its performance and outlook during its full-year 2025 earnings call on February 11, 2026.

This strategic repositioning of Conifer, backed by a major capital infusion and strong operational results, positions Tenet Healthcare to aggressively pursue technological leadership in the RCM sector while continuing to strengthen its overall financial foundation.